期刊文献+

危重病患者抗生素治疗的剂量调节原则 被引量:6

下载PDF
导出
摘要 危重病患者的高病死率仍是目前全球范围重症监护医师面临的重大挑战,有效的抗生素疗法对挽救这类患者的生命至关重要。然而,危重病患者病理生理学的变化常引起抗生素药动学性质发生改变,如未合理调节给药方案将导致耐药性的出现和/或治疗失败。本文基于常见抗生素(氨基糖苷类、β-内酰胺类、碳青霉烯类、糖肽类、氟喹诺酮类、林可酰胺类、利奈唑胺、替加环素和粘菌素E等)的药效学特征以及在危重病患者体内药动学性质的潜在改变,提出了给药剂量调节的一般推荐方案。需要说明的是,在根据患者的具体情况制定个体化给药方案时,临床医师还应了解抗生素的已知不良反应及药物相互作用,在力争治疗效果最佳化的同时使耐药风险降至最低。
出处 《国外医药(抗生素分册)》 CAS 2011年第2期65-71,共7页 World Notes on Antibiotics
  • 相关文献

同被引文献43

  • 1朱珠,王宏钠,徐小薇.HPLC测定人血清中头孢他啶浓度[J].中国药学杂志,1995,30(6):351-353. 被引量:9
  • 2尹明,李银平.危重病中白蛋白的应用——两难中的选择[J].中国危重病急救医学,2006,18(10):637-640. 被引量:21
  • 3傅强,徐小薇,李大魁.高效液相色谱法测定人血清中氯林可霉素[J].中国医院药学杂志,1997,17(2):69-71. 被引量:3
  • 4FALAGAS M E, SIEMPOS I I , VARDAKAS K Z. Linezolid versus a glycopeptides or lactam for treatment of Grampositive bacterial infection; a meta-analysis of randomized controlled trials [ J ]. Lancet Infect Dis, 2008,8 ( 1 ) :53-66.
  • 5UDEA T, TAKESUE Y, NAKAJIMA K, et al. High-dose regimen to achieve novel target trough concentration in teicoplanin [ J ]. J Infec Chemother,2014,20 ( 1 ) :43-47.
  • 6PEA F, BROLLO L, VIALE P, et al. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose [ J ]. J Antimicrob Chemother,2003,51 (4) :971-975.
  • 7BRINK A J,RICHARDS G A, CUMMINS R R, et al. Reco- mmendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis[ J ]. Int J Antimicrob Agents, 2008,32 ( 5 ) : 455 - 458.
  • 8ROBERTS J A, STOVE D, WAELE J J, et al. Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons form the DALI Study [ J ]. Int J Antimicrob Agents, 2014,43 ( 5 ) :423-430.
  • 9Matouskova I, Janout V. Current knowledge of methicillin- resistant Staphylococcus aureus and community-associated methicillin-resistant Staphylococcus aureus[J]. Biomed Pap Med Fac Univ Palacky Olomoue Czech Repub, 2008, 152 (2): 191-202.
  • 10Sun H K, Kuti J L, Nicolau D P. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program[J]. Crit Care Med, 2005, 33 (10): 2222-2227.

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部